Healthcare Bullish Stocks: Dyax Corp. (NASDAQ:DYAX), Incyte Corporation (NASDAQ:INCY), ISIS Pharmaceuticals (NASDAQ:ISIS), NPS Pharmaceuticals (NASDAQ:NPSP)

Dyax Corp. (NASDAQ:DYAX) was a big mover last session, as the company saw its shares rise nearly 6% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. Dyax Corp. (NASDAQ:DYAX) currently has a Zacks Rank #3 (Hold). Dyax Corp. (NASDAQ:DYAX) stock performance was 5.90% in last session and finished the day … Continue reading Healthcare Bullish Stocks: Dyax Corp. (NASDAQ:DYAX), Incyte Corporation (NASDAQ:INCY), ISIS Pharmaceuticals (NASDAQ:ISIS), NPS Pharmaceuticals (NASDAQ:NPSP)

Biotech Gainers: Inovio Pharmaceuticals Inc (NYSEMKT:INO), Northwest Biotherapeutics (NASDAQ:NWBO), Peregrine Pharmaceuticals (NASDAQ:PPHM), Dyax (NASDAQ:DYAX)

Trade-Ideas LLC identified Inovio Pharmaceuticals Inc (NYSEMKT:INO) as a “barbarian at the gate” (strong stocks crossing above resistance with today’s range greater than 200%) candidate. Inovio Pharmaceuticals, Inc. (NYSEMKT:INO), together with its subsidiaries, engages in the discovery and development of synthetic vaccines and immune therapies focusing on cancers and infectious diseases. Currently there are 3 analysts that rate Inovio Pharmaceuticals Inc (NYSEMKT:INO) a buy, no … Continue reading Biotech Gainers: Inovio Pharmaceuticals Inc (NYSEMKT:INO), Northwest Biotherapeutics (NASDAQ:NWBO), Peregrine Pharmaceuticals (NASDAQ:PPHM), Dyax (NASDAQ:DYAX)

Over the past few trading days, sleepy microcap Aastrom Biosciences Inc (NASDAQ:ASTM) has exploded from $3.88 3/19/14 to a peak of $6.24 after a positive article from respected analyst Jason Napodano. Seeking Alpha’s sophisticated readership is more than capable of analyzing Aastrom Biosciences Inc (NASDAQ:ASTM)’s balance sheet. Aastrom Biosciences Inc (NASDAQ:ASTM) stock performance was -15.21% in last session and finished the day at $4.18. Traded … Continue reading Unusual Volume At Biotech Stocks: Aastrom Biosciences (NASDAQ:ASTM), 22nd Century Group (NYSEMKT:XXII), Dyax Corp. (NASDAQ:DYAX), Exelixis (NASDAQ:EXEL)

Illumina (NASDAQ:ILMN) SVP Nicholas Naclerio unloaded 2,000 shares of Illumina stock in a transaction that occurred on Monday, March 17th. Illumina, Inc. (NASDAQ:ILMN) stock performance was -5.42% in last session and finished the day at $152.60. Traded volume was 4,483,791 million shares in the last session and the average volume of the stock remained 1.99 million shares. The beta of the stock remained 0.44. Illumina, … Continue reading Healthcare Bearish Stocks: Illumina (NASDAQ:ILMN), The Clorox Co (NYSE:CLX), Dyax Corp. (NASDAQ:DYAX), Alexion Pharmaceuticals (NASDAQ:ALXN)

Tesaro Inc. (NASDAQ:TSRO) announced Thursday morning that it has entered into an exclusive, worldwide license agreement and immuno-oncology antibody collaboration with AnaptysBio Inc. TESARO Inc. (NASDAQ:TSRO) stock performance was -5.40% in last session and finished the day at $36.76. Traded volume was 732,104.00 shares in the last session and the average volume of the stock remained 469,070.00 shares. TESARO Inc. (NASDAQ:TSRO) insider ownership is 21.88%. … Continue reading Biotech Top Losers: TESARO Inc. (NASDAQ:TSRO), Dyax Corp. (NASDAQ:DYAX), Regulus Therapeutics (NASDAQ:RGLS), Cara Therapeutics (NASDAQ:CARA)

Inovio Pharmaceuticals Inc (NYSEMKT:INO) on Feb. 27 announced the pricing of an underwritten public offering of 18,966,000 shares of common stock for a public offering price of $2.90 per share. The gross proceeds to Inovio from this offering are expected to be approximately $55 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company. Inovio Pharmaceuticals Inc (NYSEMKT:INO) … Continue reading Biotech Gainers In News: Inovio Pharmaceuticals (NYSEMKT:INO), Dendreon Corporation (NASDAQ:DNDN), BioCryst Pharmaceuticals (NASDAQ:BCRX), Dyax (NASDAQ:DYAX)